General Info
Location: Karenslyst allé 8b
Country: Norway
Industries: Pharmaceuticals, Biotechnology, Diagnostics, Medical devices and instruments, Consumer Health
Investment Regions:
Investment Stages: pre-seed, seed
Website: http://www.birkventure.no/
vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Latest verifiable investments and news on Birk Venture’s own website and linked press items show portfolio activity dates mainly between 2016 and 2017 (e.g., Zelluna Immunotherapy activity 2016-2017, BerGenBio activity and IPO referenced in 2017). No investments or portfolio additions dated within the past 12 months were found. The most recent cited investment-related item is from 2017 (BerGenBio/Targovax/Zelluna news). Therefore, the last known investment occurred more than 12 months ago – the appropriate classification is not-active. The investor invested in Zelluna Immunotherapy (founding/investment noted in 2016).
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Hans Ivar …
CEO
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Birk Venture
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI